Ethic Inc’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
267,456
+47,921
| +22% | +$724K | 0.07% | 282 |
|
|
2025
Q1 | $3.27M | Sell |
219,535
-106,772
| -33% | -$1.59M | 0.07% | 303 |
|
|
2024
Q4 | $4.32M | Sell |
326,307
-113,512
| -26% | -$1.5M | 0.09% | 233 |
|
|
2024
Q3 | $6.11M | Sell |
439,819
-16,055
| -4% | -$223K | 0.15% | 156 |
|
|
2024
Q2 | $5.9M | Buy |
455,874
+16,055
| +4% | +$208K | 0.14% | 158 |
|
|
2024
Q1 | $6.11M | Buy |
439,819
+74,488
| +20% | +$1.03M | 0.15% | 156 |
|
|
2023
Q4 | $5.21M | Sell |
365,331
-96,516
| -21% | -$1.38M | 0.15% | 159 |
|
|
2023
Q3 | $7.14M | Buy |
461,847
+58,945
| +15% | +$912K | 0.25% | 85 |
|
|
2023
Q2 | $6.33M | Buy |
402,902
+47,123
| +13% | +$740K | 0.23% | 93 |
|
|
2023
Q1 | $5.86M | Buy |
355,779
+60,971
| +21% | +$1M | 0.24% | 96 |
|
|
2022
Q4 | $4.6M | Buy |
294,808
+155,562
| +112% | +$2.43M | 0.25% | 98 |
|
|
2022
Q3 | $1.81M | Sell |
139,246
-19,617
| -12% | -$254K | 0.12% | 211 |
|
|
2022
Q2 | $2.23M | Sell |
158,863
-87,765
| -36% | -$1.23M | 0.16% | 165 |
|
|
2022
Q1 | $3.53M | Buy |
246,628
+106,763
| +76% | +$1.53M | 0.24% | 99 |
|
|
2021
Q4 | $1.91M | Buy |
139,865
+50,384
| +56% | +$687K | 0.15% | 173 |
|
|
2021
Q3 | $1.47M | Buy |
89,481
+21,748
| +32% | +$356K | 0.15% | 176 |
|
|
2021
Q2 | $1.14M | Buy |
67,733
+10,438
| +18% | +$176K | 0.14% | 188 |
|
|
2021
Q1 | $1.05M | Buy |
57,295
+21,350
| +59% | +$390K | 0.19% | 142 |
|
|
2020
Q4 | $654K | Buy |
35,945
+315
| +0.9% | +$5.73K | 0.17% | 149 |
|
|
2020
Q3 | $636K | Buy |
35,630
+8,346
| +31% | +$149K | 0.24% | 106 |
|
|
2020
Q2 | $489K | Buy |
27,284
+5,088
| +23% | +$91.2K | 0.28% | 101 |
|
|
2020
Q1 | $337K | Buy |
22,196
+3,957
| +22% | +$60.1K | 0.28% | 123 |
|
|
2019
Q4 | $360K | Buy |
+18,239
| New | +$360K | 0.26% | 125 |
|